Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PERSIST: Oral Levosimendan in Severe Chronic Heart Failure
NCT00130884Phase 2Completed
- Sponsor
- Orion Corporation
- Start
- Mar 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of levosimendan in chronic heart failure (CHF), sponsored by Orion Corporation. Started Mar 2005; status: completed.
02
Drugs
levosimendan
03
Conditions
chronic heart failure (CHF)
Beyond the preview
Go deeper on NCT00130884.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00130884.